Landmark Financial Advisors, LLC Amgen Inc Transaction History

Landmark Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	SELL	$225.79 - $275.2 $9,031 - $11,008	-40 Reduced 4.56%	838 $202,000
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $2,290 - $2,910	-10 Reduced 1.13%	878 $0
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $6,921 - $7,702	-30 Reduced 3.27%	888 $216,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $201,289 - $222,679	918 New	918 $231,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Landmark Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Landmark Financial Advisors, LLC with notifications on news.